| CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice F Jadidi-Niaragh, F Atyabi, A Rastegari, N Kheshtchin, S Arab, ... Journal of Controlled Release 246, 46-59, 2017 | 160 | 2017 |
| Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy HR Mirzaei, H Mirzaei, SY Lee, J Hadjati, BG Till Cancer letters 380 (2), 413-423, 2016 | 132 | 2016 |
| Epi-drugs and Epi-miRs: moving beyond current cancer therapies R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ... Current cancer drug targets 16 (9), 773-788, 2016 | 130 | 2016 |
| Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin C Lane, J Leitch, X Tan, J Hadjati, JL Bramson, Y Wan Cancer research 64 (4), 1509, 2004 | 107 | 2004 |
| Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications M Mirahmadian, N Parvaneh, A Salavati, S Abdollahzade, N Rezaei, ... J Investig Allergol Clin Immunol 17 (5), 321-328, 2007 | 99 | 2007 |
| Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents H Mirzaei, A Sahebkar, A Avan, M R Jaafari, R Salehi, H Salehi, ... Current Medicinal Chemistry 23 (5), 455-463, 2016 | 98 | 2016 |
| Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factor M Farokhi, F Mottaghitalab, MA Shokrgozar, J Ai, J Hadjati, M Azami Materials Science and Engineering: C 35, 401-410, 2014 | 93 | 2014 |
| Prolonged persistence of chimeric antigen receptor (CAR) T cell in adoptive cancer immunotherapy: challenges and ways forward L Jafarzadeh, E Masoumi, K Fallah-Mehrjardi, HR Mirzaei, J Hadjati Frontiers in immunology 11, 511610, 2020 | 90 | 2020 |
| Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer N Kheshtchin, S Arab, M Ajami, R Mirzaei, M Ashourpour, N Mousavi, ... Cancer Immunology, Immunotherapy 65, 1159-1167, 2016 | 89 | 2016 |
| Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles F Jadidi-Niaragh, F Atyabi, A Rastegari, E Mollarazi, M Kiani, A Razavi, ... Tumor Biology 37, 8403-8412, 2016 | 82 | 2016 |
| Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor S Arab, N Kheshtchin, M Ajami, M Ashurpoor, A Safvati, A Namdar, ... Tumor Biology 39 (3), 1010428317695021, 2017 | 76 | 2017 |
| Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses A Dashti, M Ebrahimi, J Hadjati, A Memarnejadian, SM Moazzeni Cancer letters 374 (1), 175-185, 2016 | 73 | 2016 |
| Adenosine blockage in tumor microenvironment and improvement of cancer immunotherapy S Arab, J Hadjati Immune network 19 (4), 2019 | 71 | 2019 |
| Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice K Amirshahrokhi, AR Dehpour, J Hadjati, M Sotoudeh, M Ghazi-Khansari Toxicology and applied pharmacology 232 (1), 119-124, 2008 | 70 | 2008 |
| Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells E Masoumi, L Jafarzadeh, HR Mirzaei, K Alishah, K Fallah-Mehrjardi, ... Journal of Experimental & Clinical Cancer Research 39, 1-12, 2020 | 68 | 2020 |
| Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia A Memarian, M Nourizadeh, F Masoumi, M Tabrizi, AH Emami, ... Tumor Biology 34, 531-542, 2013 | 68 | 2013 |
| Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice G Ghalamfarsa, A Rastegari, F Atyabi, H Hassannia, M Hojjat‐Farsangi, ... Journal of cellular physiology 233 (10), 7165-7177, 2018 | 65 | 2018 |
| Gene-knocked out chimeric antigen receptor (CAR) T cells: tuning up for the next generation cancer immunotherapy HR Mirzaei, H Pourghadamyari, M Rahmati, A Mohammadi, JS Nahand, ... Cancer letters 423, 95-104, 2018 | 57 | 2018 |
| Immunomodulatory effects of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells M Saeidi, A Masoud, Y Shakiba, J Hadjati, MM Bonab, MH Nicknam, ... Iranian Journal of Allergy, Asthma and Immunology, 37-49, 2013 | 55 | 2013 |
| PiggyBac as a novel vector in cancer gene therapy: current perspective H Mirzaei, A Sahebkar, MR Jaafari, J Hadjati, SH Javanmard, HR Mirzaei, ... Cancer Gene Therapy 23 (2), 45-47, 2016 | 53 | 2016 |
Hamid Reza Mirzaei, PhDSenior Research Scientist at Memorial Sloan Kettering Cancer Center在 mskcc.org 的电子邮件经过验证
